Validation of the French Translation of the SOSI-M

Validation of the French Translation of SOSI-M in Healthy Children and in Children With Mild to Moderate Neurodevelopmental Disorder

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07353112

Enrollment

Registered

2026-01-20

Start date

2026-02-01

Completion date

2026-04-01

Last updated

2026-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodevelopmental Disorders

Brief summary

The aim of this study is to validate the French version of the SOSI-M test on healthy children as well as on children with neurodevelopmental disorders (NDDs). Therefore, the investigators will conduct a video recording of the test administration on a group of healthy children and on a group of children with NDDs. The research question is: Is the French translation of the SOSI-M test equivalent, in terms of functionality and expected results, to the original version for a population of healthy children and children with mild to moderate neurodevelopmental disorders? The hypothesis is that the psychometric properties of the French version are similar to those of the original version. Secondly, the investigators will investigate: Does the difference in socio-cultural context between healthy Belgian and Senegalese children influence the SOSI-M score? The hypothesis is that healthy Belgian children obtain better scores compared to healthy Senegalese children. The scores of the two groups will be compared with each other and with those obtained in previous studies. Intra- and inter-rater reliability will also be assessed.

Interventions

DIAGNOSTIC_TESTAdministration of the French translation of the SOSI-M test.

Filmed administration of the French translation of the SOSI-M test We will then compare the scores of the two groups between them and with the scores obtained by other studies. There will be two operators that will evaluate each video 2 times (3 weeks between each evaluation) in order to mesure the metrologics qualities like fidelity.

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

5 Years to 14 Years

Healthy volunteers

Yes

Inclusion criteria

For the groupe of children with neurodevelopmental disorders : Inclusion criteria * neurodevelopmental disorder (NDD) * speak french and understand instructions in French * and have not been assessed with the SOSI-M in the past 6 months.

Exclusion criteria

* Severe motor/cognitive impairment * uncorrected visual/auditory impairment * cerebral palsy diagnosis For the neurotypical children : Inclusion criteria : \- speak french and understand french instructions

Design outcomes

Primary

Measure	Time frame	Description
SOSI-M score	1 day for the filmed passation of the french version of the sosi-m test.	For the total raw score : 0 = Abnormal 64 = Normal development of the child

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026